16667 Hymus Boulevard
Kirkland, QC H9H 4R9
Canada
514-261-4735
https://www.chitogenx.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Pierre Laurin B.Sc.Pharm., M.Sc. | Interim CEO & Independent Chairman | N/A | N/A | 1961 |
Mr. Luc Mainville M.B.A, M.B.A. | Senior VP & CFO | 132.12k | N/A | 1964 |
Mr. Guy-Paul Allard | VP of Legal Affairs & Corporate Secretary | N/A | N/A | N/A |
Dr. Jonathan Sackier | Senior Vice President of Medical Affairs | 166.65k | N/A | N/A |
Mr. Frederic Dumais | Director of Communications & Investor Relations | N/A | N/A | N/A |
Benedek Simo | Controller | N/A | N/A | N/A |
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
ChitogenX Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.